Published 8 hours ago • loading... • Updated 8 hours ago

CastleVax Announces Initiation of a Phase 2 Study Evaluating Its Mucosally-delivered, Next Generation, COVID-19 Vaccine Candidate

NEW YORK--(BUSINESS WIRE)--Nov 4, 2025-

+2 Reposted by 2 other sources

8 hours ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources3

Leaning Left0Leaning Right0Center1Last Updated7 hours agoBias Distribution

100% Center

100% Center

Untracked bias

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

The Caledonian Record broke the news in 8 hours ago on Tuesday, November 4, 2025.

Sources are mostly out of (0)